Dentinox Infant Colic Drops provides symptomatic support relevant to conditions involving episodic or fluctuating manifestations of digestive discomfort in infants. Products in this category are relevant for managing symptoms of excess gas. This preparation is commonly used for managing symptoms that interfere with daily functioning, such as prolonged crying and marked fussiness, particularly during acute episodes of Infant Colic.

It is primarily applied in addressing symptoms related to gastrointestinal pressure, including flatulence and abdominal distension (bloating), and is relevant for easing the resulting intense physical discomfort, specifically the characteristic griping pains. The use of this preparation supports the patient during difficult episodes by contributing to easing the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable.

“The primary goal is to provide supportive relief during difficult episodes of recurrent gas-related discomfort, and may contribute to improved comfort.”

---

Quick Fact: Support for Trapped Wind

Focus Area	Symptom Domain	Patient Benefit
Gastrointestinal	Gas pressure, griping pains, bloating	Assists with managing the symptom load
Infant Use	Colic, fussiness, crying	Supports general well-being during symptomatic phases

---

Regulatory References

1. Health Canada Labelling Standard for Antiflatulents

Dentinox Infant Colic Drops, which contain the active ingredient activated dimeticone, are intended for the gentle relief of wind and griping pains in babies. The medication is suitable for use in infants from birth onwards.

Who Can Use

Patient Group	Indication
Infants	Relief from wind, colic, and griping pain
Breastfed Babies	Can be administered orally
Formula-fed Babies	Can be added to the baby's bottle or administered orally

---

Who Cannot Use (Contraindications and Precautions)

Consult a healthcare professional or avoid use in the following circumstances, as specified in authoritative product information:

• Allergy: Do not administer if the baby is known to be allergic (hypersensitive) to dimeticone or any of the other ingredients, such as the parahydroxybenzoate preservatives (E218, E214, E216), which can cause allergic reactions.
• Thyroid Disorder Treatment: Use is not recommended for a baby being treated with levothyroxine or other medications for a thyroid disorder, as dimeticone may reduce the absorption and weaken the effect of the thyroid medication.
• Sugar Intolerance: The product contains sucrose. If a baby has been diagnosed with a rare hereditary problem of sugar intolerance (e.g., fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency), a doctor should be consulted before use.

Always follow the directions for a maximum of six doses per day, and seek medical advice if symptoms persist.

Interactions with other medicines and products

This product, containing the active substance activated dimeticone, has a documented interaction with one specific medicinal product: levothyroxine. Levothyroxine is a synthetic thyroid hormone used for the treatment of thyroid disorders, such as congenital hypothyroidism in infants. This interaction is primarily of concern in babies who are currently undergoing treatment for a thyroid condition.

Interaction Mechanism and Effect

The interaction occurs because activated dimeticone, which acts as a surface-active substance, may bind to levothyroxine in the gastrointestinal tract. This binding process can lead to the impaired absorption of levothyroxine, resulting in a reduced amount of the thyroid medication entering the bloodstream. The clinical consequence is a potential weakening of the levothyroxine treatment's effect.

Interaction Restriction

Due to the potential for this interaction to weaken the effect of critical medication, official regulatory information explicitly advises a restriction on use. Do not give Dentinox Infant Colic Drops if the baby is being treated for a thyroid disorder. If there is a concern about a potential interaction with levothyroxine or any other medication, advice must be sought from a qualified healthcare professional, such as a doctor or pharmacist.

How Dentinox Infant Colic Drops Works

The mechanism of action is based on a complementary, localized approach that combines physical anti-foaming with physiological muscle relaxation within the gastrointestinal tract.

---

Physical Coalescence of Trapped Gas

The core antiflatulent action comes from Activated Dimethicone, a surface-active polymer that functions as a physical agent. This compound targets the surface tension of the films surrounding numerous small, frothy, mucus-entrapped gas bubbles. By reducing this surface tension, the mechanism promotes the coalescence of these scattered microbubbles into larger pockets of free gas. This modification of gas dynamics within the gut reduces the physical pressure caused by intestinal distension and supports the clearance of the gas via eructation or flatus.

---

Modulation of Intestinal Spasm and Motility

The secondary component, Dill Oil, exerts a complementary antispasmodic effect by locally influencing the contractility of the gastrointestinal smooth muscle. This modulation supports the relaxation of the gut wall, contributing to a decrease in localized intestinal muscle spasms and the subsequent physical trapping of gas. The physiological consequence of reduced muscle tension promotes the unimpeded passage and expulsion of the larger gas pockets consolidated by the Dimethicone component.

Official Administration Guidelines

Dentinox Infant Colic Drops (containing activated dimeticone) is an oral suspension administered according to established instructions. Adherence to these guidelines ensures proper and safe use.

Standard Dosing and Frequency

The medicine is designed for oral administration using the measuring syringe provided with the pack. The standard single dose is 2.5 ml.

Administration Component	Official Instruction
Dose	2.5 ml
Route	Oral
Timing	With or after each feed
Maximum Daily Use	Not more than 6 doses in 24 hours

Preparation and Procedural Steps

Before measuring the dose, the bottle of drops must be shaken well.

The 2.5 ml dose can be given to the infant in one of two ways:

1. Directly into the baby’s mouth using the syringe.
2. Mixed into the baby’s feed in the bottle.

The medicine is suitable for infants from birth onwards at the 2.5 ml dose. After administration, the measuring syringe should be rinsed with warm water and dried; it is explicitly not suitable for steam sterilisation.

Do not exceed the maximum limit of six doses in any 24-hour period.

Research Evidence / Overview of Studies for Dentinox Infant Colic Drops

---

Evidence for use in Colic and Wind Pain in Infants

Research on the active ingredient in Dentinox Infant Colic Drops was evaluated in studies focusing on infants experiencing conditions marked by functional limitations, specifically related to wind and physical discomfort. These investigations included study designs such as randomized controlled trials (RCTs) and various observational settings. The research examined outcomes related to physical discomfort and patient-reported outcomes describing perceived discomfort in the infants, such as crying duration and measures of restlessness.

Studies concentrated on research exploring how symptoms were measured during episodes where they become more noticeable. The findings describe patterns observed in the studies regarding measurements of crying or discomfort levels over brief observation intervals. Research highlights the measurements collected during the study period which contribute to understanding symptom patterns. These results reflect the specific conditions under which they were conducted.

---

Long-term studies and follow-up

Research primarily concentrates on studies observing responses over defined time intervals that are relatively brief, such as the initial weeks of use. As a result, long-term effects are not fully established for the prolonged or continued use of the product.

There is limited information for long-term outcomes regarding the continued outcomes related to physical discomfort or the evolution of symptom patterns beyond the initial study periods. Follow-up durations were limited in many of the core studies, meaning the evidence contributes to the broader evidence landscape mainly for short-term and acute episodes.

---

Evidence in special populations

The active ingredient was evaluated in research involving infants with conditions marked by functional limitations. Most of the research was evaluated in broad infant populations relevant to the studied outcomes. Specific studies focusing on subgroup findings are uncertain for infants who may have concurrent digestive or other complex medical conditions.

Data for certain groups remain insufficient, particularly for very specific age strata or infants with other comorbid conditions that might affect outcomes related to functional imbalance.

---

What is still Uncertain about Dentinox Infant Colic Drops

Evidence is limited regarding the comprehensive long-term use of the product, as the primary data comes from research exploring short-term symptom measurements. Sample sizes were modest in some instances, and comparative evidence is lacking across certain study designs.

Evidence suggests certainty remains low when extrapolating these short-term results beyond the immediate study context. The research contributes to the broader evidence landscape, but evidence quality varies across studies.

Key Studies & References Summary of Product Characteristics - Dentinox Infant Colic Drops (Health Products Regulatory Authority)

Storage Conditions

Official regulatory documents define mandatory conditions for storing Dentinox Infant Colic Drops to maintain its quality and ensure safety:

• Temperature Limit: The medicine must not be stored above 25 °C (77°F).
• Child Safety: It must always be kept out of the sight and reach of children.
• Stability: The product should not be used past the expiry date (EXP) shown on the packaging.
• Handling: The bottle must be shaken before use, and the dosing syringe should be rinsed with warm water and dried after each use, as it is not suitable for steam sterilisation.

Disposal Instructions

Expired or unused Dentinox Infant Colic Drops must be disposed of according to official procedures to prevent environmental contamination:

• Environmental Restriction: Do not dispose of the medicine in waste-water or with household waste.
• Regulatory Procedure: The product should be returned to a pharmacist for proper disposal of pharmaceutical waste.